BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36913175)

  • 21. Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection.
    Furuta T; Sagehashi Y; Shirai N; Sugimoto M; Nakamura A; Kodaira M; Kenmotsu K; Nagano M; Egashira T; Ueda K; Yoneyama M; Ohashi K; Ishizaki T; Hishida A
    Clin Gastroenterol Hepatol; 2005 Jun; 3(6):564-73. PubMed ID: 15952098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Rapid and Accurate Method to Evaluate Helicobacter pylori Infection, Clarithromycin Resistance, and CYP2C19 Genotypes Simultaneously From Gastric Juice.
    Kuo CH; Liu CJ; Yang CC; Kuo FC; Hu HM; Shih HY; Wu MC; Chen YH; Wang HD; Ren JL; Wu DC; Chang LL
    Medicine (Baltimore); 2016 May; 95(21):e3458. PubMed ID: 27227911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Frequency of the Minor Polymorphisms in the
    Zelenskaya EM; Lifshits GI; Nikolaev KY; Donirova OS; Altayev VD; Apartsin KA; Voronina EN; Protasov KV; Sychev DA
    Genet Test Mol Biomarkers; 2020 Jun; 24(6):338-342. PubMed ID: 32392440
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of CYP2C19 Gene Polymorphisms on Proton Pump Inhibitor, Amoxicillin, and Levofloxacin Triple Therapy for Eradication of Helicobacter Pylori.
    Lin YA; Wang H; Gu ZJ; Wang WJ; Zeng XY; Du YL; Ying SS; Zhang BH
    Med Sci Monit; 2017 Jun; 23():2701-2707. PubMed ID: 28577017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effectiveness of eradication regimen based on the bacterial susceptibility and CYP2C19 genotype in children with refractory
    Zhang YD; Dong QW; Zhang SH; Gu F; Zhang Y; Song HB; Zuo NY; Zhang SS; Ma L; Ding ZL
    Zhonghua Er Ke Za Zhi; 2020 Jan; 58(1):41-45. PubMed ID: 31905475
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP3A4, CYP2C9, CYP2C19 and CYP2D6 in Han, Uighur, Hui and Mongolian Chinese populations.
    Zuo J; Xia D; Jia L; Guo T
    Pharmazie; 2012 Jul; 67(7):639-44. PubMed ID: 22888523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host Genetic Determinants Associated With Helicobacter pylori Eradication Treatment Failure: A Systematic Review and Meta-analysis.
    Shah SC; Tepler A; Chung CP; Suarez G; Peek RM; Hung A; Roumie C; Narula N
    Gastroenterology; 2021 Nov; 161(5):1443-1459. PubMed ID: 34358488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First-line eradication for Helicobacter pylori-positive gastritis by esomeprazole-based triple therapy is influenced by CYP2C19 genotype.
    Saito Y; Serizawa H; Kato Y; Nakano M; Nakamura M; Saito H; Suzuki H; Kanai T
    World J Gastroenterol; 2015 Dec; 21(48):13548-54. PubMed ID: 26730167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection.
    Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Inaba T; Yamamoto K; Okada H; Yokota K; Oguma K; Shiratori Y
    Am J Gastroenterol; 2003 Nov; 98(11):2403-8. PubMed ID: 14638340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of CYP2C19*2 allele in Roma samples: study on Roma and Hungarian population samples with review of the literature.
    Sipeky C; Weber A; Szabo M; Melegh BI; Janicsek I; Tarlos G; Szabo I; Sumegi K; Melegh B
    Mol Biol Rep; 2013 Aug; 40(8):4727-35. PubMed ID: 23645039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of IL-1 Polymorphisms, CYP2C19 Genotype and Antibiotic Resistance on Helicobacter pylori Eradication Comparing Between 10-day Sequential Therapy and 14-day Standard Triple Therapy with Four-Times-Daily-Dosing of Amoxicillin in Thailand: a Prospective Randomized Study.
    Phiphatpatthamaamphan K; Vilaichone RK; Siramolpiwat S; Tangaroonsanti A; Chonprasertsuk S; Bhanthumkomol P; Pornthisarn B; Mahachai V
    Asian Pac J Cancer Prev; 2016; 17(4):1903-7. PubMed ID: 27221874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roles of CYP2C19 Gene Polymorphisms in Susceptibility to POAG and Individual Differences in Drug Treatment Response.
    Liu XL; Jia QJ; Wang LN; Liu ZM; Liu H; Duan XC; Lyu XM
    Med Sci Monit; 2016 Jan; 22():310-5. PubMed ID: 26822491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Individuals having variant genotypes of cytochrome P450 2C19 are at increased risk of developing primary liver cancer in Han populations, without infection with the hepatitis virus.
    Li QY; Zhao NM; Wang LC; Duan HF; Ma YC; Zhang W; Zhao HW; Qin YH
    Tumour Biol; 2014 Sep; 35(9):9023-6. PubMed ID: 24906606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variants *1, *2, *3 and *17 of CYP2C19 Cytochrome among Helicobacter Pylori Carriers from Manaus, Amazonas State, Brazil.
    Netto ERA; Netto RLA; Santana MF; Moura-Neto JP; Ferreira LCL
    Asian Pac J Cancer Prev; 2021 Jul; 22(7):2289-2294. PubMed ID: 34319054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of CYP2C19, MDR1, and interleukin 1-B gene variants on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxicillin, and metronidazole.
    Gawrońska-Szklarz B; Siuda A; Kurzawski M; Bielicki D; Marlicz W; Droździk M
    Eur J Clin Pharmacol; 2010 Jul; 66(7):681-7. PubMed ID: 20376628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
    Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E
    Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of
    Fu J; Sun CF; He HY; Ojha SC; Shi H; Deng CL; Sheng YJ
    Pharmacogenomics; 2021 Aug; 22(13):859-879. PubMed ID: 34414773
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacodynamic and cytogenetic evaluation in CYP2C19*2 and CYP2C19*3 allelomorphism in South Indian population with clopidogrel therapy.
    Tantray JA; Reddy KP; Jamil K; Kumar YS
    Int J Cardiol; 2017 Feb; 229():113-118. PubMed ID: 27915083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of CYP2C19 gene polymorphism on warfarin maintenance doses in patients with non-valvular atrial fibrillation.
    Zhang H; Ma K; Liu W; Yang F; Liu J; Zhou H
    Gene; 2016 Oct; 591(1):80-84. PubMed ID: 27356304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequencies of genotypes and alleles of the functional SNPs in CYP2C19 and CYP2E1 in mainland Chinese Kazakh, Uygur and Han populations.
    Wang SM; Zhu AP; Li D; Wang Z; Zhang P; Zhang GL
    J Hum Genet; 2009 Jun; 54(6):372-5. PubMed ID: 19444287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.